New Findings May Help Bolster CRISPR/Cas9 Accuracy
David Taylor, PhD, an assistant professor in the department of molecular biosciences at UT Austin, discussed the Cas9 research conducted between 2 labs at UT Austin.
EU CHMP Gives Positive Opinion for Ide-Cel's Use in Multiple Myeloma
The recommendation comes after positive data was released from the recent phase 2 KarMMa trial.
Gene Editing Trial Underway in Pediatric Methylmalonic Acidemia
The therapy utilizes LogicBio’s GeneRide technology to insert a corrective copy of the target gene via synthetic AAV vectors.
